Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOLOGICS SAFETY TESTING INDUSTRY
2.1 Summary about Biologics Safety Testing Industry
2.2 Biologics Safety Testing Market Trends
2.2.1 Biologics Safety Testing Production & Consumption Trends
2.2.2 Biologics Safety Testing Demand Structure Trends
2.3 Biologics Safety Testing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Endotoxin Tests
4.2.2 Sterility Tests
4.2.3 Cell Line Authentication and Characterization Tests
4.2.4 Bioburden Tests
4.2.5 Cell Line Authentication
4.2.6 Residual Host Contaminant Detection Tests
4.2.7 Adventitious Agent Detection Tests
4.2.8 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Vaccine Development
4.3.2 Blood Products Testing
4.3.3 Cellular & Gene Therapy
4.3.4 Tissue and Tissue-Related Products Testing
4.3.5 Stem Cell Research
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Endotoxin Tests
5.2.2 Sterility Tests
5.2.3 Cell Line Authentication and Characterization Tests
5.2.4 Bioburden Tests
5.2.5 Cell Line Authentication
5.2.6 Residual Host Contaminant Detection Tests
5.2.7 Adventitious Agent Detection Tests
5.2.8 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Vaccine Development
5.3.2 Blood Products Testing
5.3.3 Cellular & Gene Therapy
5.3.4 Tissue and Tissue-Related Products Testing
5.3.5 Stem Cell Research
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Endotoxin Tests
6.2.2 Sterility Tests
6.2.3 Cell Line Authentication and Characterization Tests
6.2.4 Bioburden Tests
6.2.5 Cell Line Authentication
6.2.6 Residual Host Contaminant Detection Tests
6.2.7 Adventitious Agent Detection Tests
6.2.8 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Vaccine Development
6.3.2 Blood Products Testing
6.3.3 Cellular & Gene Therapy
6.3.4 Tissue and Tissue-Related Products Testing
6.3.5 Stem Cell Research
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Endotoxin Tests
7.2.2 Sterility Tests
7.2.3 Cell Line Authentication and Characterization Tests
7.2.4 Bioburden Tests
7.2.5 Cell Line Authentication
7.2.6 Residual Host Contaminant Detection Tests
7.2.7 Adventitious Agent Detection Tests
7.2.8 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Vaccine Development
7.3.2 Blood Products Testing
7.3.3 Cellular & Gene Therapy
7.3.4 Tissue and Tissue-Related Products Testing
7.3.5 Stem Cell Research
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Endotoxin Tests
8.2.2 Sterility Tests
8.2.3 Cell Line Authentication and Characterization Tests
8.2.4 Bioburden Tests
8.2.5 Cell Line Authentication
8.2.6 Residual Host Contaminant Detection Tests
8.2.7 Adventitious Agent Detection Tests
8.2.8 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Vaccine Development
8.3.2 Blood Products Testing
8.3.3 Cellular & Gene Therapy
8.3.4 Tissue and Tissue-Related Products Testing
8.3.5 Stem Cell Research
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Endotoxin Tests
9.2.2 Sterility Tests
9.2.3 Cell Line Authentication and Characterization Tests
9.2.4 Bioburden Tests
9.2.5 Cell Line Authentication
9.2.6 Residual Host Contaminant Detection Tests
9.2.7 Adventitious Agent Detection Tests
9.2.8 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Vaccine Development
9.3.2 Blood Products Testing
9.3.3 Cellular & Gene Therapy
9.3.4 Tissue and Tissue-Related Products Testing
9.3.5 Stem Cell Research
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Lonza Group
10.1.2 Charles River
10.1.3 Merck
10.1.4 SGS
10.1.5 WuXi AppTec
10.1.6 Thermo Fisher Scientific
10.1.7 Sartorius
10.1.8 Cytovance Biologics
10.1.9 Pace Analytical Services
10.1.10 Toxikon
10.2 Biologics Safety Testing Sales Date of Major Players (2017-2020e)
10.2.1 Lonza Group
10.2.2 Charles River
10.2.3 Merck
10.2.4 SGS
10.2.5 WuXi AppTec
10.2.6 Thermo Fisher Scientific
10.2.7 Sartorius
10.2.8 Cytovance Biologics
10.2.9 Pace Analytical Services
10.2.10 Toxikon
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Biologics Safety Testing Product Type Overview
Table Biologics Safety Testing Product Type Market Share List
Table Biologics Safety Testing Product Type of Major Players
Table Brief Introduction of Lonza Group
Table Brief Introduction of Charles River
Table Brief Introduction of Merck
Table Brief Introduction of SGS
Table Brief Introduction of WuXi AppTec
Table Brief Introduction of Thermo Fisher Scientific
Table Brief Introduction of Sartorius
Table Brief Introduction of Cytovance Biologics
Table Brief Introduction of Pace Analytical Services
Table Brief Introduction of Toxikon
Table Products & Services of Lonza Group
Table Products & Services of Charles River
Table Products & Services of Merck
Table Products & Services of SGS
Table Products & Services of WuXi AppTec
Table Products & Services of Thermo Fisher Scientific
Table Products & Services of Sartorius
Table Products & Services of Cytovance Biologics
Table Products & Services of Pace Analytical Services
Table Products & Services of Toxikon
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Biologics Safety Testing Market Forecast (Million USD) by Region 2021f-2026f
Table Global Biologics Safety Testing Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Biologics Safety Testing Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Biologics Safety Testing Market Forecast (Million USD) Share by Demand 2021f-2026f